The power of genetics and environment in indoor agriculture
How can a crop’s biology be manipulated through breeding for higher profits in the fast-growing indoor agriculture market? Vonnie Estes digs in.
How can a crop’s biology be manipulated through breeding for higher profits in the fast-growing indoor agriculture market? Vonnie Estes digs in.
St. Louis-based Peptyde Bio hopes to strengthen the power of bio-fungicides with its platform that designs and discovers anti-microbial peptides.
The deal will enable CoverCress to further commercialize its namesake winter oilseed product and bring farmers another source of revenue.
Enko will use the funding to advance its pipeline of crop protection chemistries that provide an alternative to outdate chemical-based products.
With herbicide resistance on the rise, Moa Technology wants to “replenish the toolbox” available to farmers, says CEO Virginia Corless.
Administering a vaccine in animal feed is far safer for workers and requires a lot less labor than injecting each animal individually.
Fund II will invest in ag biotech and digital solutions up and down the agrifood value chain, from fintech solutions to crop science and animal health.
The US-based company provides ag biotech startups with many of the complex processes and equipment required to grow genetically engineered plants at scale.
“We have additional insecticide candidates at earlier stages in our pipeline, as well as our first fungicidal candidates,” CEO Anna Rath tells AFN.
Top Ag Biotech investment deals in 2021 covered gene editing, farm inputs, animal health solutions, and biofertilizers, among others.
When it comes to crops, biologicals are all the rage as a means to reduce agriculture’s environmental footprint – and increasingly as a solution to supply chain disruption. Decoy says livestock will be next.
Access to talent, investors, and new technologies are among the benefits CTC and CoverCress have found in St Louis ag biotech community BRDG Park.
Startups developing biological crop inputs secured a total of $892 million in funding last year.
Greenlight Biosciences develops RNA products for agriculture and human health, including in the Covid-19 vaccine arena.
The Boston, US-based startup says its natural, microbial alternative to traditional nitrogen fertilizer is crop-agnostic, non-GMO, and cost-effective for farmers facing rising fertilizer costs.
The Seoul-based startup closed a $15 million Series B round last month, with the Asian Development Bank among the participating investors.
The biological inputs market is predicted to grow at a CAGR of 11.9% over the next five years, compared to chemicals’ 3.7%, according to recent market research.
There is “no non-engineered way” to fight climate change at scale and in time, says chief science officer Ellen Jorgensen.
It seems counterintuitive that shorter crops can result in enhanced yields; but they are more resistant to high winds and other extreme weather events, writes Bayer’s Richard Lawrence.
“The insights from this agreement will [inform] how we grow, separate, and treat our cranberries to optimize for target health benefits and sustainability.”